Global Non-alcoholic Steatohepatitis (NASH) Market: Strong Product Pipeline is Anticipated to Boost the Industry Growth During the Forecast Period

The global Non-alcoholic Steatohepatitis (NASH) market is expected to grow at growth rate of 25.2% to reach USD 2.29 billion by 2025. This comprehensive study reveals the market estimate numbers for different market segments. Along with that, the study covers qualitative insights, strategic benchmarking and thorough competitive landscaping in the report spreading over 150 pages.

Non-alcoholic Steatohepatitis (NASH) is the most prevalent form of a progressive liver disease condition. Patients suffering from this condition have often had problems including type 2 diabetes, obesity, and cardiovascular diseases. Also, this condition is the major reason for severe complications such as cirrhosis. Non-alcoholic Steatohepatitis treatment is considered to be an effective method to prevent NASH progression to cirrhosis. Rising prevalence of nonalcoholic fatty liver disease (NAFLD) drives market growth significantly. For instance, the National Health and Nutrition Examination Survey (NHANES) recently found that around 30% of NAFLD prevalence is registered in the U.S.

Furthermore, as per the National Institutes of Health (NIH), the prevalence of hepatocellular carcinoma and alcoholic fatty liver is increasing, affecting more than 50 million populations worldwide. Such factors are anticipated to surge in NASH prevalence, driving the market growth. In addition, favorable government initiatives pertaining to the development of this disease drugs support industry growth. For example, the NASH Education Program and Paediatric NAFLD/NASH Program (GENFIT) were started by various organizations in order to address unmet needs related to NASH. On the other side, identification of NASH is difficult and currently, liver biopsy is only procedure available to identify the difference between NASH and NAFLD.

To request free sample copy:
www.analystviewmarketinsights.com/request_sample/av126/

Key Takeaways:
- Serum biomarkers segment held the largest share of the global market, accounted for more than 40% share. Benefits such as its ability to distinguish simple steatosis from NASH offers a competitive advantage over other product segments.
- On contrary, hepatic fibrosis biomarkers are expected to grow with the highest growth rate due to rising interest of companies to invest in this product.
- However, poorly suited regulatory and reimbursement guidelines pose as a threat to the global market
- Depending upon applications, the pharmaceutical industry accounted for the highest revenue share and is expected to grow with the highest CAGR over the study period
- Growing obese populations coupled with rising diabetic patients in developed regions such as North America and Europe support the regional growth
- Companies such as Allergan, Intercept, Bio-Rad Laboratories, Inc., Prometheus Laboratories Inc., Galmed Pharmaceuticals, Gilead Sciences, Enzo Biochem, Inc., and Quest Diagnostic are the key players in this market
- The competitive rivalry is high. Key players are acquiring small companies to strengthen their market position. For example, Allergan is heavily investing in R&D activities to develop a new treatment for NASH
- With the acquisitions of Akarna Therapeutics, Ltd. (AKN-083) and Tobira Therapeutics (Cenicriviroc (CVC) and Evogliptin), the company has further strengthened its market position

Browse full report with in-depth ToC on “Non-alcoholic Steatohepatitis (NASH) Market, By Types, By Application, and Geography – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025” at
www.analystviewmarketinsights.com/report-highlight-nonalcoholic-steatotic-hepatitis-nash-market-126/

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPES
- Serums biomarkers
- Hepatic fibrosis biomarkers
- Oxidative stress biomarkers
- Apoptosis biomarkers
- Others

MARKET, BY APPLICATION
- Pharma
- Hospitals
- Academic Institutes
- others

MARKET, BY REGION
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
- Rest of the World

MARKET, BY COUNTRY
- U.S.
- Canada
- Germany
- France
- India
- China

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include additional 10 profiles of companies):
- Allergan
- Intercept
- Bio-Rad Laboratories, Inc.
- Prometheus Laboratories Inc.
- Galmed Pharmaceuticals
- Gilead Sciences
- Enzo Biochem, Inc.
- Quest Diagnostic

Key benefits of the report:
• The report presents macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
• Thorough analysis of relevant statistical data to estimate the market paradigms
• Exceptional understanding of region and country specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
• Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Find out more by getting in touch: https://www.analystviewmarketinsights.com/get-in-touch/

About AnalystView Market Insights
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact us for more details:
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.